Multiple Sclerosis News and Research

Latest Multiple Sclerosis News and Research

NIH researchers develop new tool to better understand brain disorders

A new tool developed by researchers at the National Institutes of Health has determined, for the first time, how two distinct sets of neurons in the mouse brain work together to control movement.

14 May 2018

FDA approves new drug to treat MS in pediatric patients

The U.S. Food and Drug Administration today approved Gilenya (fingolimod) to treat relapsing multiple sclerosis (MS) in children and adolescents age 10 years and older. This is the first FDA approval of a drug to treat MS in pediatric patients.

14 May 2018

Why the drugmaker that paid Trump’s lawyer $1.2 million is so worried

President Donald Trump didn't mention Novartis or other drugmakers by name last year when he said the industry is "getting away with murder."

11 May 2018

FDA seeks order of permanent injunction to stop two stem cell clinics from marketing stem cell products

The U.S. Food and Drug Administration, in two complaints filed today in federal court, is seeking permanent injunctions to stop two stem cell clinics from marketing stem cell products without FDA approval and for significant deviations from current good manufacturing practice requirements.

10 May 2018

Researchers find link between depression and memory problems, brain aging

Depression in older adults may be linked to memory problems, according to a study published in the May 9, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

9 May 2018

Akili Interactive closes $55 million financing to advance digital medicine platform for treatment of cognitive dysfunction

Akili Interactive, a leading prescription digital medicine company developing novel treatments for cognitive dysfunction, today announced that it has successfully closed a $55 million Series C financing led by Temasek.

9 May 2018

Scientists discover how protein molecules regulate formation of myelin sheaths

According to the Deutsche Multiple Sklerose Gesellschaft, around 200,000 people in Germany suffer from multiple sclerosis- a serious neurological condition that has no known cure.

8 May 2018

Study identifies molecule that may be critical to repair of white matter

A new study identifies a molecule that may be critical to the repair of white matter, the fatty tissue wrapped around parts of brain cells that helps speed up communication. Damage to white matter is associated with several conditions, including multiple sclerosis and cerebral palsy, and can occur in the brains of preterm babies.

7 May 2018

New research illustrates how beneficial bacteria establish robust gut colonization

The mammalian gut is warm, moist, and incredibly nutrient-rich--an environment that is perfect for bacterial growth. The communities of "good bacteria" in the gut, commonly referred to as the microbiome, are vital partners for the body, helping to digest fiber, extract nutrients, and prevent various diseases.

4 May 2018

Frequent saunas may have beneficial effects on vascular health

Taking frequent saunas may be linked to a lower risk of stroke, according to a study published in the May 2, 2018, online issue of Neurology, the medical journal of the American Academy of Neurology.

3 May 2018

Scientists find way to inhibit growth of specific gut microbes associated with diseases

Emerging evidence suggests that microbes in the digestive system have a big influence on human health and may play a role in the onset of disease throughout the body.

3 May 2018

New results reinforce COPAXONE 40 mg/mL as safe and effective for RMS patients

Teva Pharmaceutical Industries Ltd., today announced up to 7-year efficacy, safety and tolerability results from the Glatiramer Acetate Low-Frequency Administration (GALA) open-label extension study of COPAXONE (glatiramer acetate injection) 40 mg/mL administered subcutaneously three-times-a-week for the treatment of relapsing forms of multiple sclerosis (RMS).

28 Apr 2018

Study shows link between restless legs syndrome symptoms and brain structure

People with restless legs syndrome may have changes in a portion of the brain that processes sensory information, according to a study published in the April 25, 2018, online issue of Neurology®, the medical journal of the American Academy of Neurology.

26 Apr 2018

Researchers gain ground-breaking insights into how inflammatory diseases work

A research team from Queen's University Belfast, in collaboration with an international team of experts, have made ground-breaking insights into how inflammatory diseases work.

25 Apr 2018

Rehabilitation technique for stroke appears beneficial for multiple sclerosis patients

A rehabilitation technique originally developed for stroke has now been shown to also be effective for improving function for people with multiple sclerosis, a neurodegenerative disease.

24 Apr 2018

Exposure to toxin found in sheep may be linked to development of MS

Exposure to a toxin primarily found in sheep could be linked to the development of multiple sclerosis in humans, new research suggests.

23 Apr 2018

New non-invasive nerve stimulation may offer relief for people with hand tremor

People with tremors in their hands from a condition called essential tremor may find some relief from a new, non-invasive type of nerve stimulation, according to a preliminary scientific abstract released today that will be presented at the American Academy of Neurology's 70th Annual Meeting in Los Angeles, April 21 to 27, 2018.

20 Apr 2018

Interaction between dioxin and HLA gene variant activates events associated with rheumatoid arthritis

It has been known for more than three decades that individuals with a particular version of a gene -; human leukocyte antigen (HLA) -; have an increased risk for rheumatoid arthritis.

19 Apr 2018

Environmental pollutants found to worsen rheumatoid arthritis

Scientists have uncovered a link between the risk of developing rheumatoid arthritis and environmental pollutants, such as cigarette smoke.

19 Apr 2018

New microscopy techniques allow quasi-biochemical studies on living T cells

A joint study by the TU Wien and the Vienna School of Medicine has now led to a surprising result. While most opinion leaders in the field reasoned that T cell receptors must interact with one another for effective immune-signaling, the Viennese study shows: T cell receptors act alone. The study has now been published in the journal Nature Immunology.

19 Apr 2018